Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications
American Journal of Psychiatry · 01.11.2026 · 183 (11) · 819-820
DOI: 10.1176/appi.ajp.20260628 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Psychiatry, erschienen am 01.11.2026. Verfasst von Mark Olfson. Beteiligte Einrichtung: Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University and New York State Psychiatric Institute, New York. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University and New York State Psychiatric Institute, New York.
Zitieren
APA
Olfson, M. (2026). Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications. American Journal of Psychiatry, 183(11), 819-820. https://doi.org/10.1176/appi.ajp.20260628
Vancouver
Olfson M. Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications. American Journal of Psychiatry. 2026;183(11):819-820. doi:10.1176/appi.ajp.20260628
BibTeX
@article{Olfson2026,
author = {Olfson, Mark},
title = {Psilocybin Use in Psychiatry: Clinical Practice and Public Health Implications},
journal = {American Journal of Psychiatry},
year = {2026},
volume = {183},
number = {11},
pages = {819--820},
doi = {10.1176/appi.ajp.20260628}
}
EUVIMED